The U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema.

Northwell Health partnered with Stacker to explore how a new Pap smear alternative may help prevent deaths from cervical ...

The company also issued a 2025 guidance that fell short of expectations, as some of the company’s older drugs face ...

President Trump said he would take health agencies in a new direction on the campaign trail and has chosen some controversial nominees to help him achieve his goal, including Robert F. Kennedy Jr., ...

Both Canadian Prime Minister Trudeau and Mexican President Sheinbaum said they had agreed to bolster border enforcement ...

Medpace demonstrates strong financial performance and growth in the CRO market, despite facing challenges in the short term. Read why MEDP stock is a Strong Buy.

Tariff retaliation: Mexico and Canada immediately vowed to impose tariffs of their own. The Canadian prime minister, Justin ...

Senate Majority Leader John Thune is playing dumb when it comes to Donald Trump’s significant efforts to shutter USAID. Since ...

Donald Trump’s spending freeze isn’t supposed to be in effect after a court order, but multiple Head Start programs around ...

The unprecedented pause and potential elimination of many U.S. foreign assistance programs, announced in President Trump’s ...

Neurocrine stock took a hit late Thursday after the biotech company issued a light 2025 outlook for its drug, Ingrezza.

Follow live updates and news coverage of the Senate confirmation hearing for RFK Jr. Stay up to date with real-time ...